Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis.

Yates WB, Chiong F, Zagora S, Post JJ, Wakefield D, McCluskey P.

Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):280-284. doi: 10.1097/APO.0000000000000244.

2.

Optic Perineuritis Due to Tuberculosis.

Yates WB, Nothling S, Lawlor M.

J Neuroophthalmol. 2019 Jun;39(2):257-259. doi: 10.1097/WNO.0000000000000717.

PMID:
30204621
3.

Post-surgical versus post-intravitreal injection endophthalmitis: changing patterns in causative flora.

Ong AP, Angbue Te N, Zagora SL, Symes RJ, Yates W, Chang AA, McCluskey PJ, Simunovic MP.

Clin Exp Ophthalmol. 2019 Jan;47(1):57-62. doi: 10.1111/ceo.13345. Epub 2018 Jul 16.

PMID:
29931722
4.

Adalimumab for the treatment of refractory active and inactive non-infectious uveitis.

Lee JT, Yates WB, Rogers S, Wakefield D, McCluskey P, Lim LL.

Br J Ophthalmol. 2018 Dec;102(12):1672-1678. doi: 10.1136/bjophthalmol-2017-311234. Epub 2018 Feb 19.

PMID:
29459430
5.

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.

Savitz JB, Teague TK, Misaki M, Macaluso M, Wurfel BE, Meyer M, Drevets D, Yates W, Gleason O, Drevets WC, Preskorn SH.

Transl Psychiatry. 2018 Jan 24;8(1):27. doi: 10.1038/s41398-017-0073-7.

6.

Phenylethanolamine N-methyltransferase gene expression in PC12 cells exposed to intermittent hypoxia.

Khurana S, Peng S, McDonald E, Yates W, Venkataraman K, Tai TC.

Neurosci Lett. 2018 Feb 14;666:169-174. doi: 10.1016/j.neulet.2017.12.056. Epub 2017 Dec 27.

PMID:
29288726
7.

Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.

Quinn D, Barnes CN, Yates W, Bourdet DL, Moran EJ, Potgieter P, Nicholls A, Haumann B, Singh D.

Pulm Pharmacol Ther. 2018 Feb;48:71-79. doi: 10.1016/j.pupt.2017.10.003. Epub 2017 Oct 4.

8.

Etiology and Clinical Features of Ocular Inflammatory Diseases in a Tertiary Referral Centre in Sydney, Australia.

Zagora SL, Symes R, Yeung A, Yates W, Wakefield D, McCluskey PJ.

Ocul Immunol Inflamm. 2017;25(sup1):S107-S114. doi: 10.1080/09273948.2016.1247871. Epub 2016 Nov 30.

PMID:
27901620
9.

HLA-B27 Anterior Uveitis: Immunology and Immunopathology.

Wakefield D, Yates W, Amjadi S, McCluskey P.

Ocul Immunol Inflamm. 2016 Aug;24(4):450-9. doi: 10.3109/09273948.2016.1158283. Epub 2016 May 31. Review.

PMID:
27245590
10.

Roll-to-Roll Nanomanufacturing of Hybrid Nanostructures for Energy Storage Device Design.

Oakes L, Hanken T, Carter R, Yates W, Pint CL.

ACS Appl Mater Interfaces. 2015 Jul 8;7(26):14201-10. doi: 10.1021/acsami.5b01315. Epub 2015 Jun 24.

PMID:
26053115
11.

Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.

Yates WB, Vajdic CM, Na R, McCluskey PJ, Wakefield D.

Ophthalmology. 2015 Feb;122(2):265-73. doi: 10.1016/j.ophtha.2014.08.024. Epub 2014 Oct 11.

PMID:
25312044
12.

Genetic analysis of low BMI phenotype in the Utah Population Database.

Yates WR, Johnson C, McKee P, Cannon-Albright LA.

PLoS One. 2013 Dec 11;8(12):e80287. doi: 10.1371/journal.pone.0080287. eCollection 2013.

13.

Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?

Yates WB, McCluskey PJ, Wakefield D.

J Ophthalmic Inflamm Infect. 2013 May 31;3(1):48. doi: 10.1186/1869-5760-3-48.

14.

Executive function in eating disorders: the role of state anxiety.

Billingsley-Marshall RL, Basso MR, Lund BC, Hernandez ER, Johnson CL, Drevets WC, McKee PA, Yates WR.

Int J Eat Disord. 2013 May;46(4):316-21. doi: 10.1002/eat.22086. Epub 2013 Jan 28.

PMID:
23354876
15.

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial.

Savitz J, Preskorn S, Teague TK, Drevets D, Yates W, Drevets W.

BMJ Open. 2012 Feb 22;2(1):e000643. doi: 10.1136/bmjopen-2011-000643. Print 2012.

16.

Early-onset Major Depressive Disorder in men is associated with childlessness.

Yates WR, Meller WH, Lund BC, Thurber S, Grambsch PL.

J Affect Disord. 2010 Jul;124(1-2):187-90. doi: 10.1016/j.jad.2009.10.024.

PMID:
19931182
17.

Phenomenology and epidemiology of panic disorder.

Yates WR.

Ann Clin Psychiatry. 2009 Apr-Jun;21(2):95-102.

PMID:
19439159
18.

Psychiatrists for medically complex patients: bringing value at the physical health and mental health/substance-use disorder interface.

Kathol RG, Kunkel EJ, Weiner JS, McCarron RM, Worley LL, Yates WR, Summergrad P, Huyse FJ.

Psychosomatics. 2009 Mar-Apr;50(2):93-107. doi: 10.1176/appi.psy.50.2.93.

PMID:
19377017
19.

Rate of inpatient weight restoration predicts outcome in anorexia nervosa.

Lund BC, Hernandez ER, Yates WR, Mitchell JR, McKee PA, Johnson CL.

Int J Eat Disord. 2009 May;42(4):301-5. doi: 10.1002/eat.20634.

PMID:
19107835
20.

Clinical utility of the Hopkins Competency Assessment Test on an inpatient geropsychiatry unit.

Wilkins KM, Lund BC, McAdams JD, Yates WR.

Am J Alzheimers Dis Other Demen. 2009 Feb-Mar;24(1):34-9. doi: 10.1177/1533317508326374. Epub 2008 Dec 1.

PMID:
19047475
21.

Attention-deficit hyperactivity symptoms and disorder in eating disorder inpatients.

Yates WR, Lund BC, Johnson C, Mitchell J, McKee P.

Int J Eat Disord. 2009 May;42(4):375-8. doi: 10.1002/eat.20627.

PMID:
19040267
22.

Gastroenterologists' perceptions of need and availability of psychiatric services for patients with hepatitis C.

Gleason O, Fucci J, Yates W.

Psychosomatics. 2008 Mar-Apr;49(2):132-6. doi: 10.1176/appi.psy.49.2.132.

PMID:
18354066
23.

Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.

Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, McGrath PJ, Thase ME, Klinkman M, Nierenberg AA, Yates WR, Fava M.

J Gen Intern Med. 2008 May;23(5):551-60. doi: 10.1007/s11606-008-0522-3. Epub 2008 Feb 5.

24.

Concurrent tracking of alcohol use and bipolar disorder symptoms.

Fossey MD, Allen MH, Yates WR.

Bipolar Disord. 2007 Nov;9(7):789-90; author reply 790-1. No abstract available.

PMID:
17988372
25.

Prevention of water jetting injuries.

Yates WD.

Occup Health Saf. 2007 Oct;76(10):64-6. No abstract available.

PMID:
17972696
26.

Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis.

Yates WR, Mitchell J, John Rush A, Trivedi M, Wisniewski SR, Warden D, Bryan C, Fava M, Husain MM, Gaynes BN.

Prim Care Companion J Clin Psychiatry. 2007;9(1):7-15.

27.

Evaluating the quality of websites offering information on female hypoactive sexual desire disorder.

Touchet BK, Warnock JK, Yates WR, Wilkins KM.

J Sex Marital Ther. 2007 Jul-Sep;33(4):329-42.

PMID:
17541851
28.

Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.

Gleason OC, Fucci JC, Yates WR, Philipsen MA.

Dig Dis Sci. 2007 Oct;52(10):2557-63. Epub 2007 Apr 12.

PMID:
17436092
29.

Opioid contract use is associated with physician training level and practice specialty.

Touchet BK, Yates WR, Coon KA.

J Opioid Manag. 2005 Sep-Oct;1(4):195-200.

PMID:
17315546
30.

A pilot study of psychiatry resident psychotherapy competency: the impact of resident attitude and demographics.

Coon KA, Yates WR, Touchet BK, Lund B.

Am J Psychother. 2006;60(2):175-85.

PMID:
16892953
31.

Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers.

Zia-Amirhosseini P, Salfi M, Leese P, Yates W, Danilenko DM, Ring B, Cesano A, Sullivan JT.

Clin Pharmacol Ther. 2006 Jun;79(6):558-69.

PMID:
16765144
32.

Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants.

Fossey MD, Otto MW, Yates WR, Wisniewski SR, Gyulai L, Allen MH, Miklowitz DJ, Coon KA, Ostacher MJ, Neel JL, Thase ME, Sachs GS, Weiss RD; Step-BD Investigators.

Am J Addict. 2006 Mar-Apr;15(2):138-43.

PMID:
16595351
33.

Primary care specialty, resident status, and male gender correlate with controlled drug contract use.

Touchet BK, Yates WR, Fischer IT, Coon KA.

Prim Care Companion J Clin Psychiatry. 2005;7(6):275-80.

34.

Major depressive disorder in hepatitis C: an open-label trial of escitalopram.

Gleason OC, Yates WR, Philipsen MA.

Prim Care Companion J Clin Psychiatry. 2005;7(5):225-30.

35.

Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation.

Cleland JG, Sullivan JT, Ball S, Horowitz JD, Agoram B, Rosser D, Yates W, Tin L, Fuentealba P, Burton PB.

J Cardiovasc Pharmacol. 2005 Aug;46(2):155-61.

PMID:
16044026
36.

Aripiprazole and depression in schizoaffective disorder.

Errico JR, Yates WR.

Am J Psychiatry. 2005 Mar;162(3):626-7. No abstract available.

PMID:
15741489
37.

Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D.

Yates WR, Mitchell J, Rush AJ, Trivedi MH, Wisniewski SR, Warden D, Hauger RB, Fava M, Gaynes BN, Husain MM, Bryan C.

Gen Hosp Psychiatry. 2004 Nov-Dec;26(6):421-9.

PMID:
15567207
38.

The impact of fear of HIPAA violation on patient care.

Touchet BK, Drummond SR, Yates WR.

Psychiatr Serv. 2004 May;55(5):575-6.

PMID:
15128967
39.

Suicide attempt due to a misunderstood HIPAA notice.

Gleason OC, Yates WR.

Am J Psychiatry. 2004 Feb;161(2):374. No abstract available.

PMID:
14754795
40.

Plasma levels of citalopram in depressed patients with hepatitis C.

Gleason OC, Yates WR, Philipsen MA, Isbell MD, Pollock BG.

Psychosomatics. 2004 Jan-Feb;45(1):29-33.

PMID:
14709758
41.

Combined internal medicine/psychiatry and family practice/psychiatry training programs 1999-2000: residents' perspectives.

Carney CP, Pitkin AK, Malis R, Yates WR.

Acad Psychiatry. 2002 Summer;26(2):110-6.

PMID:
12824153
42.

Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use.

Perry PJ, Kutscher EC, Lund BC, Yates WR, Holman TL, Demers L.

J Forensic Sci. 2003 May;48(3):646-51.

PMID:
12762541
43.

Sauna and hot tub warnings.

Tavakoli SA, Yates WR.

Psychosomatics. 2003 May-Jun;44(3):261-2. No abstract available.

PMID:
12724512
44.

Recovery rates for anorexia nervosa.

Johnson CL, Lund BC, Yates WR.

Am J Psychiatry. 2003 Apr;160(4):798; author reply 798. No abstract available.

PMID:
12668382
45.

Electronic archiving with PubMed Central--next steps into the future.

Yates WD.

Can Vet J. 2003 Feb;44(2):101-2. English, French. No abstract available.

46.

Testosterone therapy in late-life major depression in males.

Perry PJ, Yates WR, Williams RD, Andersen AE, MacIndoe JH, Lund BC, Holman TL.

J Clin Psychiatry. 2002 Dec;63(12):1096-101.

PMID:
12523867
47.

Readmission rates for adjustment disorders: comparison with other mood disorders.

Jones R, Yates WR, Zhou MH.

J Affect Disord. 2002 Sep;71(1-3):199-203.

PMID:
12167517
48.

An open-label trial of citalopram for major depression in patients with hepatitis C.

Gleason OC, Yates WR, Isbell MD, Philipsen MA.

J Clin Psychiatry. 2002 Mar;63(3):194-8.

PMID:
11926717
49.
50.

Tramadol dependence with no history of substance abuse.

Yates WR, Nguyen MH, Warnock JK.

Am J Psychiatry. 2001 Jun;158(6):964. No abstract available.

PMID:
11384913

Supplemental Content

Support Center